UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS. James Hawkins 03/11/2025 James Hawkins 03/11/2025 Personal psychedelic experience as a training qualification for facilitators: A thematic analysis of qualitative interviews with psilocybin experts Read More James Hawkins 03/11/2025 James Hawkins 03/11/2025 Beyond prohibition: A public health analysis of naturalistic psychedelic use Read More James Hawkins 03/11/2025 James Hawkins 03/11/2025 Five-year outcomes of psilocybin-assisted therapy for major depressive disorder Read More James Hawkins 02/11/2025 James Hawkins 02/11/2025 Embracing change: impermanence acceptance mediates differences in death processing between long-term ayahuasca users and non-users Read More James Hawkins 02/11/2025 James Hawkins 02/11/2025 Psychedelic therapy, positive emotional experiences, and the central role of self-compassion Read More James Hawkins 02/11/2025 James Hawkins 02/11/2025 Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder Read More James Hawkins 02/11/2025 James Hawkins 02/11/2025 'I am melting, help me': The 30-year-old drug website that transformed psychedelic research Read More James Hawkins 02/11/2025 James Hawkins 02/11/2025 Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Read More James Hawkins 12/09/2025 James Hawkins 12/09/2025 Single treatment with MM120 (Lysergide) in generalized anxiety disorder: A randomized clinical trial Read More James Hawkins 09/08/2025 James Hawkins 09/08/2025 Germany’s landmark compassionate use program for psilocybin: A new wave for psychedelic medicine in Europe Read More James Hawkins 09/08/2025 James Hawkins 09/08/2025 Psychedelic drug DMT and near death experiences have long been linked – my study is the first to explore the connection in depth Read More James Hawkins 09/08/2025 James Hawkins 09/08/2025 Health-related behavioral changes following the use of psychedelics in naturalistic settings Read More James Hawkins 20/07/2025 James Hawkins 20/07/2025 MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study Read More James Hawkins 16/07/2025 James Hawkins 16/07/2025 Psilocybin-assisted therapy for obsessive-compulsive disorder: A review Read More James Hawkins 16/07/2025 James Hawkins 16/07/2025 Naturalistic psychedelic use and changes in depressive symptoms Read More James Hawkins 16/07/2025 James Hawkins 16/07/2025 Psilocybin treatment extends cellular lifespan and improves survival of aged mice Read More James Hawkins 16/07/2025 James Hawkins 16/07/2025 Single-dose (10mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder Read More James Hawkins 05/07/2025 James Hawkins 05/07/2025 Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies Read More James Hawkins 02/07/2025 James Hawkins 02/07/2025 Medicinal cannabis use among people with obsessive compulsive disorder: Changes in quality of life after three months Read More James Hawkins 02/07/2025 James Hawkins 02/07/2025 Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial Read More Older Posts
James Hawkins 03/11/2025 James Hawkins 03/11/2025 Personal psychedelic experience as a training qualification for facilitators: A thematic analysis of qualitative interviews with psilocybin experts Read More
James Hawkins 03/11/2025 James Hawkins 03/11/2025 Beyond prohibition: A public health analysis of naturalistic psychedelic use Read More
James Hawkins 03/11/2025 James Hawkins 03/11/2025 Five-year outcomes of psilocybin-assisted therapy for major depressive disorder Read More
James Hawkins 02/11/2025 James Hawkins 02/11/2025 Embracing change: impermanence acceptance mediates differences in death processing between long-term ayahuasca users and non-users Read More
James Hawkins 02/11/2025 James Hawkins 02/11/2025 Psychedelic therapy, positive emotional experiences, and the central role of self-compassion Read More
James Hawkins 02/11/2025 James Hawkins 02/11/2025 Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder Read More
James Hawkins 02/11/2025 James Hawkins 02/11/2025 'I am melting, help me': The 30-year-old drug website that transformed psychedelic research Read More
James Hawkins 02/11/2025 James Hawkins 02/11/2025 Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Read More
James Hawkins 12/09/2025 James Hawkins 12/09/2025 Single treatment with MM120 (Lysergide) in generalized anxiety disorder: A randomized clinical trial Read More
James Hawkins 09/08/2025 James Hawkins 09/08/2025 Germany’s landmark compassionate use program for psilocybin: A new wave for psychedelic medicine in Europe Read More
James Hawkins 09/08/2025 James Hawkins 09/08/2025 Psychedelic drug DMT and near death experiences have long been linked – my study is the first to explore the connection in depth Read More
James Hawkins 09/08/2025 James Hawkins 09/08/2025 Health-related behavioral changes following the use of psychedelics in naturalistic settings Read More
James Hawkins 20/07/2025 James Hawkins 20/07/2025 MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study Read More
James Hawkins 16/07/2025 James Hawkins 16/07/2025 Psilocybin-assisted therapy for obsessive-compulsive disorder: A review Read More
James Hawkins 16/07/2025 James Hawkins 16/07/2025 Naturalistic psychedelic use and changes in depressive symptoms Read More
James Hawkins 16/07/2025 James Hawkins 16/07/2025 Psilocybin treatment extends cellular lifespan and improves survival of aged mice Read More
James Hawkins 16/07/2025 James Hawkins 16/07/2025 Single-dose (10mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder Read More
James Hawkins 05/07/2025 James Hawkins 05/07/2025 Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies Read More
James Hawkins 02/07/2025 James Hawkins 02/07/2025 Medicinal cannabis use among people with obsessive compulsive disorder: Changes in quality of life after three months Read More
James Hawkins 02/07/2025 James Hawkins 02/07/2025 Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial Read More
